The quality of life impact of the COVID-19 pandemic and lockdowns for people living with multiple sclerosis (MS): evidence from the Australian MS Longitudinal Study.

Glen James Henson Ingrid A van der Mei Bruce V Taylor Paul Blacklow Suzi B Claflin Andrew J Palmer Carol Hurst Julie A Campbell

Published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2024)

We found that COVID-19-related adversity reduced the HRQoL of PwMS. Our HSU estimates can be used in health economic models to evaluate lockdown cost-effectiveness for people with complex and chronic (mainly neurological) diseases.

Keyphrases

multiple sclerosis
coronavirus disease
mass spectrometry
sars cov
white matter
ms ms
healthcare
public health
mental health
health information
early life
drug induced
risk assessment
brain injury
blood brain barrier
cerebral ischemia